IDEAYA Biosciences Inc. logo

IDEAYA Biosciences Inc.

IDYA | NASDAQ
Chart Builder DCF Calculator
$38.86
+$0.45 (+1.17%)
At close: Sep 21, 2026, 4:00 PM ET
$38.86
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$3.65B
Enterprise Value
$2.9B
Beta
-0.09
Average Volume
996.45K
Shares Outstanding (Diluted)
92.06M
Shares Change YoY
4.06%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US45166A1025

Price Performance

Price Change 1M
-1.7%
Price Change 3M
11.3%
Price Change 6M
23.8%
Price Change YTD
14.8%
Price Change 1Y
49.9%
Price Change 3Y
40.6%
Price Change 5Y
53.1%
1M CAGR (ann.)
6.0%
1Y CAGR (ann.)
57.2%
5Y CAGR (ann.)
7.6%
All-Time CAGR
18.3%

Valuation

PE Ratio
-20.03
Forward PE
N/A
PEG Ratio
-1.02
Forward PEG
1.96
PS Ratio
15.78
Forward PS
32.00
PB Ratio
3.08
P/FCF Ratio
-19.45
P/Adj. FCF Ratio
-14.23
P/OCF Ratio
-19.14
EV/Sales
12.37
EV/EBIT
-16.54
EV/EBITDA
-17.09
EV/FCF
-15.24
Earnings Yield
-5.0%
FCF Yield
-5.1%
Adj. FCF Yield
-7.0%

Financial Health

Net Cash
$828.96M
Total Debt
$29.31M
Cash & Short-Term Investments
$828.96M
Total Assets
$1.31B
Current Ratio
10.45
Quick Ratio
10.45
Debt / Equity Ratio
0.02
Debt / EBITDA
-0.17
Debt / FCF
-0.15
OCF / Debt
-6.38
Interest Coverage
0.00
Altman Z-Score
19.22
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
-13.3%
Operating Profit Margin
-92.7%
EBITDA Margin
-90.8%
Net Profit Margin
-74.8%
FCF Margin
-81.2%
Adj. FCF Margin
-110.9%
SBC / Revenue
29.8%
SBC Impact (per share)
-36.7%

Returns

Return on Assets
-13.4%
Return on Equity
-16.5%
Return on Invested Capital
-17.7%
Return on Capital Employed
-17.7%
Return on Tangible Assets
-13.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
73.1%
Revenue CAGR 5Y
45.8%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
4.7%
EPS CAGR 5Y
-12.4%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-13.4%
FCF CAGR 5Y
-26.2%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
26
EPS Growth Next 3Y
7.1%
Revenue Growth Next 3Y
34.3%
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$1.18
EPS Growth Est (next Q)
-188.6%
Revenue Est (next Q)
$6.84M
Revenue Growth Est (next Q)
-96.7%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$57
Price Target Upside
46.7%

Cash Flow

Operating Cash Flow
$-186.83M
Free Cash Flow
$-190.01M
Adj. Free Cash Flow
$-259.75M
FCF Per Share
-$2.06
OCF Per Share
-$2.03
OCF/S Ratio
-79.8%

Income Statement

Revenue
$234.13M
Gross Profit
$63.39M
Operating Income
$-216.95M
EBITDA
$-169.39M
Net Income
$-175.02M
EPS (Diluted)
-$1.94
Revenue / Employee
$1.61M
Profit / Employee
$-1.21M
Employees
145

© 2026 bestshares.com. All rights reserved.